A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshop.

[1]  M. Johnston,et al.  Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. , 2003, International journal of radiation oncology, biology, physics.

[2]  P. Hoskin,et al.  International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  A Mouelle-Sone,et al.  Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). , 2002, International journal of radiation oncology, biology, physics.

[4]  A. Bezjak,et al.  Primary treatment endpoint following palliative radiotherapy for painful bone metastases: need for a consensus definition? , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  R. Sciuto,et al.  Metastatic bone pain palliation with 89‐Sr and 186‐Re‐HEDP in breast cancer patients , 2001, Breast Cancer Research and Treatment.

[6]  K. Vella,et al.  Use of consensus development to establish national research priorities in critical care , 2000, BMJ : British Medical Journal.

[7]  P. Hoskin,et al.  A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05) , 2000, International journal of radiation oncology, biology, physics.

[8]  E. Neugebauer.  Development of a consensus-assisted protocol--a new approach to improve study design. , 1999, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[9]  J Kievit,et al.  The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  J. Yarnold.  8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working Party , 1999 .

[11]  M. Brundage,et al.  Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group. , 1998, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

[12]  R. Rubens,et al.  A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. , 1997, European journal of cancer.

[13]  M. Kenney,et al.  Determining research priorities in pediatric nursing: a Delphi study. , 1997, Journal of pediatric nursing.

[14]  F J van Dijk,et al.  Priorities in occupational health research: a Delphi study in The Netherlands. , 1997, Occupational and environmental medicine.

[15]  R. Slawson,et al.  Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. , 1996, International journal of radiation oncology, biology, physics.

[16]  D. Machin,et al.  A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. , 1992, British Journal of Cancer.

[17]  D. Girling,et al.  Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  M. Rotman,et al.  A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22. , 1996, International journal of radiation oncology, biology, physics.